Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Gourin · SciRah

Researcher profile · Semantic Scholar

M. Gourin

Share profile

M. Gourin — researcher profile on SciRah

h-index: 17
Works: 69
Citations: 882

Most-cited papers

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
F. Garnache-Ottou, C. Vidal, S. Biichlé, F. Renosi +122 more
2019Blood Advances103 citations Open access
Semantic Scholar
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML
Arsène M. Mékinian, Lin-Pierre Zhao, S. Chevret, K. Desseaux +32 more
2022Leukemia93 citations
Semantic Scholar
Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup.
M. Hospital, T. Prebet, S. Bertoli, X. Thomas +17 more
2014Blood77 citations Open access
Semantic Scholar
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
V. Santini, Jennifer Schemenau, A. Levis, E. Balleari +21 more
2013Blood76 citations Open access
Semantic Scholar
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents
C. Kelaidi, Sophie Park, R. Sapena, O. Beyne-Rauzy +16 more
2013Leukemia67 citations Open access
Semantic Scholar
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
M. Sébert, Aline Renneville, C. Bally, P. Peterlin +20 more
2019Haematologica50 citations Open access
Semantic Scholar
Ivosidenib Monotherapy Is Effective in Patients with IDH1 Mutated Myelodysplastic Syndrome (MDS): The Idiome Phase 2 Study By the GFM Group
M. Sébert, T. Cluzeau, Odile Beyne Rauzy, Aspasia Stamatoulas Bastard +17 more
2021Blood42 citations Open access
Semantic Scholar
Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
V. Bardet, O. Wagner-Ballon, J. Guy, Céline Morvan +12 more
2015Haematologica40 citations Open access
Semantic Scholar
CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment
M. Touati, M. Delage-Corre, J. Monteil, J. Abraham +11 more
2015Leukemia and Lymphoma36 citations
Semantic Scholar
Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies
S. Trarieux-Signol, S. Moreau, M. Gourin, A. Penot +3 more
2014BMC Palliative Care33 citations Open access
Semantic Scholar
Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients
L. Pascal, O. Beyne-Rauzy, S. Bréchignac, S. Maréchaux +8 more
2013British Journal of Haematology29 citations
Semantic Scholar
Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas
L. Dubanet, Hafidha Bentayeb, B. Petit, A. Olivrie +10 more
2015British Journal of Cancer28 citations Open access
Semantic Scholar
An elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes: pathophysiological implications.
L. Polivka, M. Madrange, C. Bulai-Livideanu, S. Barete +52 more
2023Journal of Allergy and Clinical Immunology26 citations Open access
Semantic Scholar
Therapy related myeloid neoplasms following PARP inhibitors: real-life experience.
Vincent Marmouset, J. Decroocq, S. Garciaz, G. Étienne +39 more
2022Clinical Cancer Research25 citations Open access
Semantic Scholar
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study.
P. Peterlin, Y. Le Bris, P. Turlure, P. Chevallier +18 more
2023The Lancet Haematology23 citations
Semantic Scholar
Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myélodysplasies
C. Kelaidi, A. Stamatoullas, O. Beyne-Rauzy, E. Raffoux +16 more
2010Haematologica19 citations Open access
Semantic Scholar
c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study
N. Faumont, O. Taoui, D. Collares, J. Jais +11 more
2021Frontiers in Oncology17 citations Open access
Semantic Scholar
CPX 351 As First Line Treatment in Higher Risk MDS. a Phase II Trial By the GFM
P. Peterlin, P. Turlure, P. Chevallier, M. Gourin +15 more
2021Blood17 citations Open access
Semantic Scholar
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases
V. Jachiet, L. Ricard, P. Hirsch, F. Malard +34 more
2022Clinical and Experimental Medicine (Testo stampato)11 citations
Semantic Scholar
Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment
M. Sébert, C. Bally, P. Peterlin, O. Beyne-Rauzy +18 more
201611 citations
Semantic Scholar
Association of mastocytosis with inflammatory joint diseases: a series of 31 patients.
B. Bader-Meunier, Christina Bulai Livideanu, C. Larroche, I. Durieu +22 more
2014Seminars in Arthritis & Rheumatism11 citations
Semantic Scholar
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO
A. Kubasch, A. Giagounidis, G. Metzgeroth, A. Jonášová +25 more
2022Leukemia7 citations Open access
Semantic Scholar
Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial
J. Viallard, P. Agapé, V. Barlogis, G. Cozon +13 more
2016BMC Immunology7 citations Open access
Semantic Scholar
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study
Josquin Moraly, J. Rossignol, C. Rouzaud, Thomas Gabas +41 more
2024American journal of hematology/oncology5 citations Open access
Semantic Scholar
Histological characterization of liver involvement in systemic mastocytosis
J. Rossignol, Danielle Canioni, A. Aouba, Cristina Bulai-Livideanu +53 more
2024Liver international (Print)5 citations Open access
Semantic Scholar
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C‐finding treated with midostaurin
M. Heiblig, C. Gourguechon, Philippe Guilpain, Cristina Bulai-Livideanu +54 more
2024American journal of hematology/oncology3 citations Open access
Semantic Scholar
Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis
J. Rossignol, S. Georgin-lavialle, Danielle Canioni, Omer Beganović +58 more
2024Haematologica3 citations Open access
Semantic Scholar
Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders
J. Rossignol, A. Ouedrani, C. Livideanu, S. Barete +51 more
2022Journal of Allergy and Clinical Immunology: In Practice3 citations Open access
Semantic Scholar
CD68+ Tumor-Associated Macrophages Predict Unfavorable Treatment Outcomes in Classic Hodgkin's Lymphoma in Correlation with Early FDG-PET Assessment Results
M. Touati, M. Delage-Corre, J. Monteil, Agnes Olivrie-Gamaury +7 more
20113 citations
Semantic Scholar
A Phase II Study of the Efficacy and Tolerance of Azacytidine (AZA) in Steroid Dependent/Refractory Systemic Autoimmune and Inflammatory Disorders (SAID) Associated with MDS or CMML (GFM- AZA-SAID -trial)
A. Mékinian, Lin-Pierre Zhao, K. Desseaux, Rose Rose +24 more
2021Blood2 citations Open access
Semantic Scholar
AML-347 SELECT-AML-1: Phase 2 Randomized Trial of Tamibarotene in Combination With Venetoclax and Azacitidine in Adult Patients With Previously Untreated AML With RARA Overexpression, Who Are Ineligible for Standard Induction Therapy
U. Borate, Christine M. McMahon, P. Fenaux, M. Heiblig +22 more
2024Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Prognostic Characterization of Advanced Mastocytosis Patients Treated with Midostaurin According to Diagnosis and Mutation-Adjusted Risk Score: A Nation-Wide Ceremast Study of 170 Patients
M. Heiblig, C. Gourguechon, Philippe Guilpain, C. Livideanu +47 more
2023Blood1 citations
Semantic Scholar
[Interest of Apremilast in idiopathic recurrent aphthous stomatitis: Review of two clinical cases].
S. Fourmond, B. Gutiérrez, M. Gourin, S. Delaumenie +1 more
2022La Revue de medecine interne1 citations Open access
Semantic Scholar
Molecular Response Analysis By High Throughput Sequencing in Higher Risk Myelodysplastic Syndrome (HR-MDS) Treated Intensively with CPX-351
Y. Le Bris, Simon Bouzy, A. Menard, P. Turlure +16 more
2022Blood1 citations Open access
Semantic Scholar
Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response
J. Rossignol, A. Ouedrani, C. Livideanu, S. Barete +47 more
2021bioRxiv1 citations Open access
Semantic Scholar
Biomarkers of Response to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia - Results of the Europe Trial By the Emsco Network
U. Platzbecker, A. Kubasch, A. Giagounidis, G. Metzgeroth +23 more
2019Blood1 citations Open access
Semantic Scholar
French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up
J. Paillassa, E. Cornet, S. Noel, C. Tomowiak +31 more
2019Blood1 citations Open access
Semantic Scholar
The Revised IPSS (IPSS-R) Predicts Response To Erythropoietic Stimulating agents (ESA) In Pts With Classical IPSS Low Or Intermediate-1 (int 1)- MDS: A Joint Retrospective Study Of The GFM, Düsseldorf Registry and Fism
V. Santini, Jennifer Schemenau, A. Levis, E. Balleari +20 more
20131 citations
Semantic Scholar
Acces to hypomethylating agents in elderly Acute Myeloid Leukemia in French care network
M. Gourin, S. Girault, P. Turlure, J. Fargeas +5 more
20131 citations
Semantic Scholar
Qualitative research on the unwillingness of elderly patients' to participate in clinical research
S. Trarieux-Signol, M. Gourin, C. Tisseuil, J. Fargeas +3 more
20131 citations
Semantic Scholar
FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?
Marine Boulesteix, M. Touati, J. Abraham, S. Verbeke +8 more
20121 citations
Semantic Scholar
148 Myelodysplastic syndrome in very elderly patients: practice in the real life. Preliminary results on a monocentric cohort
M. Gourin, N. Gachard, F. Trimoreau, J. Abraham +5 more
20111 citations
Semantic Scholar
Long-Term Outcome of Anemic Non Del 5q Lower-Risk MDS Refractory to or Relapsing After Erythropoiesis Stimulating Agents (ESAs)
C. Kelaidi, Sophie Park, R. Sapena, O. Beyne-Rauzy +16 more
20101 citations
Semantic Scholar
“Non-Hodgkin's Lymphomas and Diabetes of Type 2 in Elderly Patients: Impact On Management in the Real Life”.
S. Moreau, L. Réménieras, M. Touati, M. Rapp +8 more
20091 citations
Semantic Scholar
Thrombosis in individuals with high oxygen affinity hemoglobin‐associated erythrocytosis: A systematic review and analysis of a national cohort
Marie Laloi, N. Maaziz, Victor Bobée, P. Joly +16 more
2026HemaSphere0 citations Open access
Semantic Scholar
Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.
M. Sébert, E. Clappier, Sylvie Chevret, Hugo Bergugnat +21 more
2026Leukemia0 citations
Semantic Scholar
Tamibarotene with venetoclax and azacitidine in RARA+ acute myeloid leukemia: results from the SY-1425-202 study
T. Cluzeau, U. Borate, Christine M. McMahon, P. Fenaux +20 more
2026Blood neoplasia0 citations Open access
Semantic Scholar
ANALYSIS OF BRENTUXIMAB VEDOTIN USE IN THE SETTING OF ADULTS PATIENTS WITH POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AMONG THE FRENCH NATIONAL K‐VIROGREF DATABASE
F. Bijou, A. Tichadou, C. Jacquet, P. Piazzola +7 more
2025Hematological Oncology0 citations
Semantic Scholar
Supplement Article
M. Alessi, B. Bačová, Jitka Pistkova, D. Heřman +67 more
2025International Journal of Laboratory Hematology0 citations
Semantic Scholar
SELECT-AML-1: Phase 2 Randomized Trial of Tamibarotene in Combination With Venetoclax and Azacitidine in Adult Patients With Previously Untreated AML With RARA Overexpression, Who Are Ineligible for Standard Induction Therapy
U. Borate, Christine M. McMahon, P. Fenaux, M. Heiblig +22 more
2024Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Fenaux×17
Invite
P. Fenaux — researcher profile on SciRah
S. Dimicoli-Salazar×16
Invite
S. Dimicoli-Salazar — researcher profile on SciRah
P. Peterlin×14
Invite
P. Peterlin — researcher profile on SciRah
L. Adès×14
Invite
L. Adès — researcher profile on SciRah

×13

Invite

Sophie Park — researcher profile on SciRah

Invite

L. Terriou — researcher profile on SciRah

Invite

F. Chermat — researcher profile on SciRah

Invite

R. Sapena — researcher profile on SciRah

D. Bordessoule×10

Invite

D. Bordessoule — researcher profile on SciRah

Jose Torregrosa-Diaz×10

Invite

Jose Torregrosa-Diaz — researcher profile on SciRah

L. Lhermitte×9

Invite

L. Lhermitte — researcher profile on SciRah

Invite

T. Cluzeau — researcher profile on SciRah